PMID: 15223825Jun 30, 2004Paper

Molecular targeting of antiangiogenic factor 16K hPRL inhibits oxygen-induced retinopathy in mice

Investigative Ophthalmology & Visual Science
Hao PanMaria B Grant

Abstract

To examine the ability and mechanism of the 16 kDa N-terminal fragment of human prolactin (16K hPRL) in the inhibition of abnormal retinal neovascularization. The 16K hPRL-encoding sequence was inserted into an adenoviral vector (16K-Ad). Western blot analysis verified the expression of 16K hPRL and inhibition of proliferation, confirming functional activity of the 16K hPRL in virus-infected adult bovine aortic endothelial (ABAE) cells. 16K hPRL inhibited retinal neovascularization in a mouse model of oxygen-induced retinopathy. The ability of recombinant 16K hPRL expressed in E. coli (r16K hPRL) was compared to that of endostatin in inducing apoptosis of cultured human retinal endothelial cells (HREC). 16K was expressed in virus-infected ABAE cells and resulted in a dose-dependent inhibition of cell proliferation. Eyes injected with 16K-Ad showed a reduction in preretinal neovascularization of 82.3 +/- 9.3% (P < 0.00001) when compared to uninjected controls. r16K hPRL was 100 times more potent than endostatin in inducing apoptosis in HRECs. Intravitreal administration of 16K hPRL inhibited neovascularization in the mouse model of oxygen-induced retinopathy. 16K hPRL stimulated apoptosis in HRECs and inhibited cell proliferatio...Continue Reading

Citations

Jan 22, 2008·Journal of Mammary Gland Biology and Neoplasia·Carmen ClappGonzalo Martínez de la Escalera
Jun 26, 2012·Current Heart Failure Reports·Denise Hilfiker-KleinerKaren Sliwa
Jul 17, 2012·Nature Medicine·Yuji OkunoYoshiaki Kubota
Aug 30, 2007·Molecular Therapy : the Journal of the American Society of Gene Therapy·Ngoc-Quynh-Nhu NguyenIngrid Struman
Apr 27, 2013·The Journal of Clinical Investigation·Julie HalkeinIngrid Struman
Sep 16, 2006·Proceedings of the National Academy of Sciences of the United States of America·Ngoc-Quynh-Nhu NguyenIngrid Struman
Aug 10, 2007·Expert Opinion on Investigational Drugs·Cristina Hernández, Rafael Simó
Dec 22, 2007·Experimental Eye Research·José C RiveraCarmen Clapp
Jan 24, 2007·Survey of Ophthalmology·Michael DorrellMartin Friedlander
Mar 18, 2015·Nature Reviews. Endocrinology·Valérie BernardNadine Binart
Feb 10, 2007·Cell·Denise Hilfiker-KleinerHelmut Drexler
Jun 12, 2008·American Journal of Physiology. Endocrinology and Metabolism·Carmen ClappGonzalo Martínez de la Escalera
Oct 1, 2009·Physiological Reviews·Carmen ClappGonzalo Martínez De La Escalera
Sep 14, 2011·IUBMB Life·Jakob TriebelCarmen Clapp
Sep 6, 2019·International Journal of Molecular Sciences·Jessica K W TsangAmy C Y Lo
May 26, 2020·Journal of Neuroendocrinology·Miguel Vázquez-MembrilloCarmen Clapp
May 31, 2018·Investigative Ophthalmology & Visual Science·Hanfang ZhangBrian K Stansfield
Nov 17, 2015·Laboratory Investigation; a Journal of Technical Methods and Pathology·Nundehui Díaz-LezamaCarmen Clapp
Aug 28, 2015·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jakob TriebelCarmen Clapp
Apr 27, 2019·Frontiers in Endocrinology·Jakob TriebelCarmen Clapp
May 19, 2005·Cancer Research·Pia NybergRaghu Kalluri
Apr 13, 2006·Journal of Cell Science·Yazmín MacotelaCarmen Clapp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis